Evidence map›Paper›PMID 41159595›Full record

ReviewExpert review of anti-infective therapy2025

Bacterial vaginosis: an overlooked STI?

Sheridan D George, Olivia T Van Gerwen, Christina A Muzny

Abstract readReview
In one paragraph

Review in Expert review of anti-infective therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Bacterial vaginosis male partner treatment in the United States.American journal of obstetrics and gynecology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sheridan D GeorgeDivision of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
Olivia T Van GerwenDivision of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.
Christina A MuznyDivision of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, USA.ORCID 0000-0002-4005-3858

Funding

Microbial Interactions between Gardnerella, Prevotella, and Atopobium Prior to Incident Bacterial VaginosisR01AI146065 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MUZNY, CHRISTINA A · 2020 to 2024
$3.2M
Assessing and Promoting Vaginal Health for Transgender Men on Testosterone: A Mixed Methods StudyK23AI185322 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Olivia Telle Van Gerwen · 2024 to 2026
$474k
NIAID NIH HHS K23 AI185322NIAID NIH HHS R01 AI146065
6 · The paper itself

Abstract

introductionDespite 70+ years of research, the etiology of bacterial vaginosis (BV), the most common vaginal infection, is unknown. Numerous studies suggest that BV-associated bacteria (BVAB) are sexually transmitted. Additionally, a recent male partner treatment trial found that the addition of combination oral and topical antimicrobial therapy for regular male sexual partners to treatment of women with BV resulted in a lower rate of recurrence at 12 weeks. However, unlike other common sexually transmitted infections such as chlamydia and trichomoniasis, no sole infectious pathogen has been identified as the causative agent of BV. In addition, non-sexual factors (e.g. smoking, copper intrauterine device use, douching, and testosterone use) have been associated with an increased risk of BV in some studies. These findings underscore the complexity of BV pathogenesis and make it challenging to counsel patients on infection acquisition and prevention of recurrent disease. AREAS COVERED: This work summarizes the evidence for and against sexual transmission of BVAB. EXPERT OPINION: A large body of data provide substantial evidence suggesting that sexual activity is the predominant mode of initial BV acquisition. There are no data showing a direct causal association between non-sexual factors and BV development. Additional research investigating BV etiology is imperative.

Indexed as

Vaginosis, BacterialAnti-Bacterial AgentsFemaleHumansMaleRisk FactorsSexual BehaviorSexually Transmitted DiseasesAnti-Bacterial AgentsBacterial vaginosissexually transmitted infectionSTIvaginal dysbiosisvaginal infection

Identifiers

PMID41159595
PMCPMC13078894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.